Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Miami › NPI 1710931522
Hospital

Kendall Healthcare Group, LTD.

Kendall Healthcare Group, LTD. was paid $15.31M by Medicaid between Jan 2018 and Dec 2024, across 214 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.

33Billing provider infoKENDALL HEALTHCARE GROUP, LTD.
MIAMI, FL 33175
33aNPI1710931522assigned 05/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.31M
24GClaims655,959
24DCodes billed214
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#29 of 163
Median peer was paid$4.77M
This provider vs. median3.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201855,811$772K
2019166,648$1.85M
202093,298$1.37M
2021113,100$3.00M
2022128,517$3.88M
202365,478$2.88M
2024incomplete33,107$1.55M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 27% 48,495 43,854 $4.16M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 46,080 37,896 $3.50M
80053 Comprehensive metabolic panel 5.6% 30,823 23,788 $856K
99282 Emergency department visit for the evaluation and management, low to moderate severity 5.3% 9,938 9,304 $816K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.3% 9,002 7,078 $653K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.9% 4,385 3,649 $596K
70450 Computed tomography, head or brain; without contrast material 2.4% 5,234 3,994 $371K
87070 1.8% 8,811 8,320 $274K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.8% 2,472 2,009 $269K
80048 Basic metabolic panel (calcium, ionized) 1.6% 9,526 7,277 $241K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.5% 2,800 2,519 $232K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.4% 7,274 6,696 $208K
202 more codes
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1.0% 3,900 $156K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 5,394 $146K
G0378 Hospital observation service, per hour <1% 10,367 $139K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 5,433 $136K
96361 Intravenous infusion, hydration; each additional hour <1% 1,549 $122K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 9,346 $115K
97535 Self-care/home management training, each 15 minutes <1% 4,802 $114K
87275 <1% 15,731 $86K
76830 Ultrasound, transvaginal <1% 3,157 $84K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 3,299 $81K
71275 Computed tomographic angiography, chest, with contrast material <1% 816 $75K
80047 <1% 3,329 $73K
81001 <1% 13,262 $70K
71046 Radiologic examination, chest; 2 views <1% 5,974 $67K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,851 $64K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,766 $64K
81003 <1% 8,506 $60K
A9270 Non-covered item or service <1% 14,757 $52K
71045 Radiologic examination, chest; single view <1% 12,771 $51K
76819 Fetal biophysical profile; without non-stress testing <1% 4,179 $51K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,431 $48K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 8,029 $44K
84112 <1% 424 $43K
85027 <1% 45,191 $43K
73630 <1% 1,068 $41K
84702 <1% 5,773 $39K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 18,856 $38K
87088 <1% 4,497 $36K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 17,822 $36K
97167 <1% 1,667 $35K
86850 <1% 4,649 $35K
S0028 Injection, famotidine, 20 mg <1% 2,540 $34K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,563 $34K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 9,625 $34K
72131 <1% 1,026 $30K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,588 $29K
73110 <1% 827 $27K
81025 <1% 4,130 $27K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,991 $24K
97163 <1% 1,376 $24K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,470 $22K
73610 <1% 1,198 $22K
84484 <1% 13,487 $22K
73130 <1% 1,148 $21K
84703 <1% 1,355 $19K
47562 <1% 12 $19K
93970 <1% 492 $17K
72125 Computed tomography, cervical spine; without contrast material <1% 1,841 $17K
12011 <1% 198 $17K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 12,374 $17K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,505 $16K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 382 $16K
73564 <1% 965 $15K
73030 <1% 763 $15K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 671 $14K
80076 <1% 1,819 $14K
87077 <1% 1,577 $13K
J2704 Injection, propofol, 10 mg <1% 1,201 $12K
87081 <1% 1,236 $12K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 886 $10K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,598 $10K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 342 $10K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,723 $9K
85730 <1% 8,313 $9K
86780 <1% 207 $9K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,214 $9K
74018 <1% 983 $8K
00400 <1% 116 $7K
87210 <1% 1,527 $7K
85610 <1% 8,563 $7K
71250 <1% 447 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,296 $7K
96375 Therapeutic injection; each additional sequential IV push <1% 6,743 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,277 $7K
76857 <1% 670 $6K
87276 <1% 15,726 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,574 $6K
82565 <1% 181 $6K
76801 <1% 797 $6K
73140 <1% 136 $6K
00840 <1% 355 $6K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 160 $5K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,985 $5K
86900 <1% 6,479 $5K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,292 $5K
86901 <1% 4,643 $5K
88307 <1% 260 $5K
29125 <1% 83 $5K
70486 <1% 125 $5K
83690 <1% 8,833 $4K
12001 <1% 52 $4K
93971 <1% 373 $4K
76770 <1% 220 $4K
99203 Doctor's office visit, new patient (routine) <1% 143 $4K
83735 <1% 4,059 $4K
87807 <1% 3,756 $3K
72128 <1% 278 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 13 $3K
97760 <1% 278 $3K
83880 <1% 1,786 $2K
87040 <1% 3,362 $2K
00300 <1% 169 $2K
73590 <1% 280 $2K
83605 <1% 3,327 $2K
12002 <1% 40 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,293 $2K
73090 <1% 180 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,657 $2K
76536 <1% 69 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,657 $2K
15004 <1% 18 $2K
A6209 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 27 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 336 $1K
J3490 Unclassified drugs <1% 644 $1K
90714 <1% 1,320 $1K
84443 Thyroid stimulating hormone (TSH) <1% 2,407 $1K
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu <1% 36 $1K
73502 <1% 73 $1K
J1815 Injection, insulin, per 5 units <1% 286 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 56 $1K
82657 <1% 35 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 973 $1K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,331 $1K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,176 $1K
84100 <1% 2,558 $929.39
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 28 $907.82
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,479 $906.58
80061 Lipid panel <1% 958 $891.39
82575 <1% 64 $883.71
88342 <1% 401 $861.07
72170 <1% 158 $854.92
86308 <1% 117 $850.71
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 28 $796.75
73080 <1% 96 $770.99
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,007 $739.68
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,950 $716.01
88304 <1% 655 $684.81
76870 <1% 14 $657.29
82550 <1% 2,095 $655.70
87045 <1% 14 $591.43
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 201 $589.72
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,614 $562.10
72100 <1% 92 $553.43
85379 <1% 733 $519.70
J0690 Injection, cefazolin sodium, 500 mg <1% 621 $506.92
76818 <1% 15 $495.32
J7050 Infusion, normal saline solution, 250 cc <1% 1,135 $479.89
70551 Magnetic resonance imaging, brain; without contrast material <1% 26 $463.92
82270 <1% 31 $445.86
82247 <1% 591 $433.68
83615 <1% 842 $407.75
10060 <1% 12 $405.09
86738 <1% 174 $377.51
J2060 Injection, lorazepam, 2 mg <1% 1,603 $369.11
85384 <1% 907 $343.89
87400 <1% 516 $335.67
82040 <1% 566 $321.87
00731 <1% 96 $315.07
84155 <1% 566 $314.26
84450 <1% 562 $314.26
84460 <1% 562 $314.26
84075 <1% 563 $314.26
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 540 $310.64
73562 <1% 30 $281.82
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 385 $270.81
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 42 $260.26
85049 <1% 35 $235.56
C1769 Guide wire <1% 184 $230.54
97116 <1% 147 $211.89
85651 <1% 686 $152.24
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 199 $78.16
86140 <1% 755 $15.66
96376 <1% 263 $14.56
82248 <1% 292 $11.94
84550 <1% 713 $10.92
85007 <1% 229 $3.54
87340 <1% 136 $3.31
J0780 Injection, prochlorperazine, up to 10 mg <1% 19 $2.50
85014 <1% 50 $2.17
85018 <1% 53 $2.17
87186 <1% 177 $1.00
J1630 Injection, haloperidol, up to 5 mg <1% 141 $0.90
J8540 Dexamethasone, oral, 0.25 mg <1% 110 $0.90
J1170 Injection, hydromorphone, up to 4 mg <1% 280 $0.50
84156 <1% 129 $0.20
J7060 5% dextrose/water (500 ml = 1 unit) <1% 56 $0.10
87205 <1% 13 $0.10
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 344 $0.00
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 0% 17 $0.00
58558 0% 12 $0.00
87420 0% 28 $0.00
S0077 Injection, clindamycin phosphate, 300 mg 0% 21 $0.00
C1758 Catheter, ureteral 0% 15 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 13 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 0% 28 $0.00
88341 0% 14 $0.00
J0456 Injection, azithromycin, 500 mg 0% 27 $0.00
87430 0% 25 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 19 $0.00
82150 0% 13 $0.00
97165 0% 13 $0.00
45380 Colonoscopy, flexible; with biopsy, single or multiple 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMAGUREAN, VICKIE (CFO)